keyword
MENU ▼
Read by QxMD icon Read
search

PCOM

keyword
https://www.readbyqxmd.com/read/27899014/differentiation-between-polycystic-ovary-syndrome-and-polycystic-ovarian-morphology-by-means-of-an-anti-m%C3%A3-llerian-hormone-cutoff-value
#1
Do Kyeong Song, Jee-Young Oh, Hyejin Lee, Yeon-Ah Sung
Background/Aims: Although increased serum anti-Müllerian hormone (AMH) level has been suggested to be a surrogate marker of polycystic ovarian morphology (PCOM), its association with polycystic ovary syndrome (PCOS) is controversial, and its diagnostic value has not been determined. We aimed to observe the relationship between the AMH level and PCOS phenotypes and to determine the optimal cutoff value of AMH for the diagnosis of PCOS in young Korean women. Methods: We recruited 207 women with PCOS (120 with PCOM and 87 without PCOM) and 220 regular cycling women with normoandrogenemia (100 with PCOM and 120 without PCOM)...
November 30, 2016: Korean Journal of Internal Medicine
https://www.readbyqxmd.com/read/27833694/large-posterior-communicating-artery-aneurysm-initial-presentation-with-reproducible-facial-pain-without-cranial-nerve-deficit
#2
Stacie Zelman, Michael C Goebel, David E Manthey, Seth Hawkins
Unruptured posterior communicating artery (PCOM) aneurysms can be difficult to diagnose and, when large (≥ 7mm), represent a substantial risk to the patient. While most unruptured PCOM aneurysms are asymptomatic, when symptoms do occur, clinical manifestations typically include severe headache (HA), visual acuity loss, and cranial nerve deficit. This case report describes an atypical initial presentation of a large unruptured PCOM aneurysm with symptoms mimicking trigeminal neuralgia, without other associated cranial nerve palsies or neurologic deficits...
November 2016: Western Journal of Emergency Medicine
https://www.readbyqxmd.com/read/27805276/anti-m%C3%A3-llerian-hormone-reflects-the-severity-of-polycystic-ovary-syndrome
#3
S L Jacob, H P Field, N Calder, H M Picton, A H Balen, J H Barth
OBJECTIVE: To examine the relationship between anti-Müllerian hormone (AMH) and the severity of the phenotype of patients with polycystic ovary syndrome (PCOS) and whether AMH can act as a diagnostic marker for PCOS? DESIGN: A prospective diagnostic utility study of AMH as a marker of PCOS. PATIENTS: A consecutive series of women presenting to a tertiary infertility clinic (n = 164) plus a second series of women prepared for assisted conception treatments (n = 89) recruited between June 2012 and May 2013...
November 2, 2016: Clinical Endocrinology
https://www.readbyqxmd.com/read/27667792/detecting-subnetwork-level-dynamic-correlations
#4
Yan Yan, Shangzhao Qiu, Zhuxuan Jin, Sihong Gong, Yun Bai, Jianwei Lu, Tianwei Yu
MOTIVATION: The biological regulatory system is highly dynamic. The correlations between many functionally related genes change over different biological conditions. Finding dynamic relations on the existing biological network may reveal important regulatory mechanisms. Currently no method is available to detect subnetwork-level dynamic correlations systematically on the genome-scale network. Two major issues hampered the development. The first is gene expression profiling data usually do not contain time course measurements to facilitate the analysis of dynamic relations, which can be partially addressed by using certain genes as indicators of biological conditions...
September 25, 2016: Bioinformatics
https://www.readbyqxmd.com/read/27530062/phenotypes-and-body-mass-in-women-with-polycystic-ovary-syndrome-identified-in-referral-versus-unselected-populations-systematic-review-and-meta-analysis
#5
Daria Lizneva, Richard Kirubakaran, Kateryna Mykhalchenko, Larisa Suturina, Galina Chernukha, Michael P Diamond, Ricardo Azziz
OBJECTIVE: To compare the prevalence of polycystic ovary syndrome (PCOS) phenotypes and obesity among patients detected in referral versus unselected populations. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Thirteen thousand seven hundred ninety-six reproductive-age patients with PCOS, as defined by the extended Rotterdam 2003 criteria. INTERVENTION(S): Review of PUBMED, EMBASE, and Cochrane Library, 2003-2016...
August 13, 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27513088/a-dismantling-study-of-the-partners-for-change-outcome-management-system
#6
Cindy W Mikeal, J Arthur Gillaspy, Michael T Scoles, John J Murphy
The current study used a dismantling design to investigate the relative efficacy of components of the Partners for Change Outcome Management System (PCOMS; Duncan, 2012). Clients (n = 94) from a university counseling center were randomly assigned to 1 of 3 conditions: PCOMS Full, Outcome Rating Scale (ORS)-only, or Session Rating Scale (SRS)-only and nested within therapists (n = 12). Results from hierarchical linear modeling and a 2-way analysis of variance indicated no statistically significant differences in outcome or rate of change on the Behavior Symptom Checklist-18 (BSI-18; Derogatis, 2001) across all 3 conditions...
August 11, 2016: Journal of Counseling Psychology
https://www.readbyqxmd.com/read/27510637/polycystic-ovary-syndrome
#7
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S E Laven, Richard S Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J Teede, Bulent O Yildiz
Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology (PCOM) - with excessive androgen production by the ovaries being a key feature of PCOS. Metabolic dysfunction characterized by insulin resistance and compensatory hyperinsulinaemia is evident in the vast majority of affected individuals. PCOS increases the risk for type 2 diabetes mellitus, gestational diabetes and other pregnancy-related complications, venous thromboembolism, cerebrovascular and cardiovascular events and endometrial cancer...
2016: Nature Reviews. Disease Primers
https://www.readbyqxmd.com/read/27504851/steroid-metabolomic-disease-signature-of-non-syndromic-childhood-obesity
#8
Aneta Gawlik, Michael Shmoish, Michaela F Hartmann, Ewa Malecka-Tendera, Stefan A Wudy, Ze'ev Hochberg
CONTEXT: The profile of urinary steroids as measured by GS-MS defines a subject's 'steroidal fingerprint'. OBJECTIVE: Here, we clustered steroidal fingerprints to characterize patients with non-syndromic childhood obesity by 'steroid metabolomic signatures'. HYPOTHESIS: Non-syndromic obesity is a symptom of different diseases and conditions, some of them will have their own signature. DESIGN: 31 steroid metabolites were quantified by GC-MS and their excretion rates were Z-transformed...
August 9, 2016: Journal of Clinical Endocrinology and Metabolism
https://www.readbyqxmd.com/read/27473310/survey-of-chinese-medicine-students-to-determine-research-and-evidence-based-medicine-perspectives-at-pacific-college-of-oriental-medicine
#9
Belinda J Anderson, Benjamin Kligler, Hillel W Cohen, Paul R Marantz
CONTEXT: Research literacy and the practice of evidence-based medicine (EBM) are important initiatives in complementary and alternative medicine (CAM), which requires cultural change within educational institutions for successful implementation. OBJECTIVE: To determine the self-assessed research and EBM perspectives of Chinese medicine Masters degree students at Pacific College of Oriental Medicine, New York campus (PCOM-NY). DESIGN AND METHODS: A survey with 17 close-ended questions and one open-ended question was administered through Survey Monkey to students at PCOM-NY...
September 2016: Explore: the Journal of Science and Healing
https://www.readbyqxmd.com/read/27459230/the-pathogenesis-of-polycystic-ovary-syndrome-pcos-the-hypothesis-of-pcos-as-functional-ovarian-hyperandrogenism-revisited
#10
Robert L Rosenfield, David A Ehrmann
Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989-1995. Subsequent studies have supported and amplified this hypothesis. When defined as otherwise unexplained hyperandrogenic oligoanovulation, two-thirds of PCOS cases have functionally typical FOH, characterized by 17-hydroxyprogesterone hyperresponsiveness to gonadotropin stimulation. Two-thirds of the remaining PCOS have FOH detectable by testosterone elevation after suppression of adrenal androgen production...
October 2016: Endocrine Reviews
https://www.readbyqxmd.com/read/27452953/a-54-year-old-man-with-12-intracranial-aneurysms-and-familial-subarachnoid-hemorrhage-case-report
#11
Sayied Abdol Mohieb Hosainey, Torstein R Meling
Unruptured intracranial aneurysms occur in 1-3 % of the general population, and the risk of rupture is generally considered to be low. However, patients with multiple aneurysms and familial predisposition carry a particular risk of subarachnoid hemorrhage (SAH). A 54-year-old hypertensive man underwent screening with a head CT angiography (CTA) because of his comorbidities. CTA revealed multiple bilateral aneurysms around the circle of Willis. At first surgery, seven aneurysms were clipped (BA, ACOM, ICA ×2, and MCA ×3), two of which were detected intraoperatively only...
October 2016: Neurosurgical Review
https://www.readbyqxmd.com/read/27320497/the-role-of-antimullerian-hormone-in-the-hormonal-workup-of-women-with-persistent-acne
#12
Kabir Sardana, Chanchal Singh, Isha Narang, Shivani Bansal, Vijay K Garg
BACKGROUND: In persistent female acne, PCOS (polycystic ovarian syndrome) is a common finding. To diagnose PCOM (polycystic ovarian morphology), transvaginal - USG is required, which is not possible in virginal women. Also, hyperandrogenemia is not consistently reported. OBJECTIVES: The aim of the study was to compare the hormonal profile of persistent acne patients with or without PCOS and to assess the role of AMH (antimullerian hormone) in persistent acne patients...
June 20, 2016: Journal of Cosmetic Dermatology
https://www.readbyqxmd.com/read/27258574/comparison-between-pulsatile-gnrh-therapy-and-gonadotropins-for-ovulation-induction-in-women-with-both-functional-hypothalamic-amenorrhea-and-polycystic-ovarian-morphology
#13
Agathe Dumont, Didier Dewailly, Pauline Plouvier, Sophie Catteau-Jonard, Geoffroy Robin
CONTEXT: Ovulation induction in patients having both functional hypothalamic amenorrhea (FHA) and polycystic ovarian morphology (PCOM) has been less studied in the literature. As results remain contradictory, no recommendations have yet been established. OBJECTIVE: To compare pulsatile GnRH therapy versus gonadotropins for ovulation induction in "FHA-PCOM" patients and to determine if one treatment strikes as superior to the other. METHODS: A 12-year retrospective study, comparing 55 "FHA-PCOM" patients, treated either with GnRH therapy (38 patients, 93 cycles) or with gonadotropins (17 patients, 53 cycles)...
June 3, 2016: Gynecological Endocrinology
https://www.readbyqxmd.com/read/27238627/introduction-determinants-of-polycystic-ovary%C3%A2-syndrome
#14
Ricardo Azziz
The polycystic ovary syndrome (PCOS) is recognized as one of the most common endocrine abnormalities of humans, with global prevalences so far generally 5%-15%. Overall, the disorder appears to be an ancient complex genetic trait, perhaps dating at least 50,000 years ago. The phenotype of PCOS can be subdivided into four different types. Phenotype A and B (hyperandrogenism + ovulatory dysfunction, with [A] and without [B] polycystic ovarian morphology [PCOM], respectively) can be considered to represent the "classic" form of the disorder...
July 2016: Fertility and Sterility
https://www.readbyqxmd.com/read/27233817/thyroperoxidase-antibodies-and-polycystic-ovarian-morphology
#15
Fahimeh Ramezani Tehrani, Mahnaz Bahri Khomami, Atieh Amouzegar, Fereidoun Azizi
OBJECTIVE: To evaluate the association between polycystic ovarian morphology (PCOM) and thyroperoxidase antibody level. METHODS: A cross-sectional study was undertaken of women aged 15-49years living in one of four provinces in Iran recruited between February 2009 and November 2010. Eligible women did not have hirsutism and were eumenorrheic. All participants underwent a comprehensive interview, clinical examination, blood sampling, and ultrasonographic assessment...
August 2016: International Journal of Gynaecology and Obstetrics
https://www.readbyqxmd.com/read/27208367/type-1-diabetes-and-polycystic-ovary-syndrome-systematic-review-and-meta-analysis
#16
REVIEW
Héctor F Escobar-Morreale, M Belén Roldán-Martín
BACKGROUND: A few small studies have reported increased prevalences of polycystic ovary syndrome (PCOS) and symptoms of androgen excess in women with type 1 diabetes. PURPOSE: We performed a systematic review and meta-analysis of studies evaluating androgen excess symptoms and PCOS in women with type 1 diabetes. DATA SOURCES: The Entrez-PubMed and Scopus electronic databases were used. STUDY SELECTION: We selected studies addressing androgen excess signs, symptoms, and disorders in girls, adolescents, and adult women with type 1 diabetes...
April 2016: Diabetes Care
https://www.readbyqxmd.com/read/27183957/resolution-of-third-nerve-palsy-despite-persistent-aneurysmal-mass-effect-after-flow-diversion-embolization-of-posterior-communicating-artery-aneurysms
#17
Tamar R Binyamin, Brian C Dahlin, Ben Waldau
Posterior communicating artery (PCOM) aneurysms may cause third nerve palsies. The optimal treatment with clipping versus coiling remains controversial. Here we report on two cases of resolution of third nerve palsy after flow diversion embolization of large and giant PCOM aneurysms without adjuvant coil placement. The resolution of third nerve palsy was not preceded by significant shrinkage of the aneurysmal sac on MRI. However, one patient showed resolution of T2-weighted signal abnormalities in the midbrain and mesial temporal lobe despite a similar size of the aneurysm...
September 2016: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://www.readbyqxmd.com/read/27151631/diagnostic-criteria-for-pcos-is-there-a-need-for-a-rethink
#18
REVIEW
Didier Dewailly
The diagnostic criteria for polycystic ovarian syndrome (PCOS) have been grouped in different classifications that have been conflicting for many years. At present, the classification of Rotterdam is the most used, but with varying frequency depending on the country and medical specialties. This classification is now >10 years old. Although its fundamental principle (two criteria required out of three) is still valid, each of its three items (oligo-anovulation (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM)) needs to be updated...
November 2016: Best Practice & Research. Clinical Obstetrics & Gynaecology
https://www.readbyqxmd.com/read/27129705/does-polycystic-ovarian-morphology-influence-the-response-to-treatment-with-pulsatile-gnrh-in-functional-hypothalamic-amenorrhea
#19
Agathe Dumont, Didier Dewailly, Pauline Plouvier, Sophie Catteau-Jonard, Geoffroy Robin
BACKGROUND: Pulsatile GnRH therapy is the gold standard treatment for ovulation induction in women having functional hypothalamic amenorrhea (FHA). The use of pulsatile GnRH therapy in FHA patients with polycystic ovarian morphology (PCOM), called "FHA-PCOM", has been little studied in the literature and results remain contradictory. The aim of this study was to compare the outcomes of pulsatile GnRH therapy for ovulation induction between FHA and "FHA-PCOM" patients in order to search for an eventual impact of PCOM...
2016: Reproductive Biology and Endocrinology: RB&E
https://www.readbyqxmd.com/read/27118252/sonographic-evaluation-of-polycystic-ovaries
#20
REVIEW
Ruo-Yan Zhu, Yee-Chee Wong, Eu-Leong Yong
The morphological features of the ovaries in women with polycystic ovary syndrome (PCOS) have been well described by ultrasound imaging technology. These include enlarged ovary size, multiple small follicles of similar size, increased ovarian stromal volume and echogenicity, peripheral distribution of the follicles, and higher stromal blood flow. Ultrasound identification of the presence of polycystic ovarian morphology (PCOM) has been recognized as a component of PCOS diagnosis. With the advance of ultrasound technology, new definition has been proposed recently...
November 2016: Best Practice & Research. Clinical Obstetrics & Gynaecology
keyword
keyword
66617
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"